CorMedix, Inc. (CRMD)

7.44 +0.06 (+0.81%) USD  |  NASDAQ  |  Apr 22, 15:06
More

CorMedix Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for CRMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Pfizer Inc. Upgrade
Altimmune, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade